Revlimid_BPA

Summary (Newest Update)

Background The Department of Veterans Affairs is issuing a Blanket Purchase Agreement (BPA) for Revlimid, a medication produced by Bristol Myers Squibb. The BPA aims to ensure the availability of this critical pharmaceutical product to support the healthcare needs of veterans. The contract is part of the agency's mission to provide high-quality medical care and services to veterans. Work Details The BPA includes the procurement of Revlimid. Specific details regarding the quantities and specifications are outlined in the attached document titled 'P03_JnA_Revlimid_DOC signed_updated_HCARedacted_'. The award includes line items numbered 1-12 for various quantities of Revlimid. Place of Performance The products will be delivered to locations managed by the Department of Veterans Affairs, specifically under the jurisdiction of NCO 15 Contracting Office located at 3450 S. 4th St. Trafficway, Leavenworth, KS 66048-5012.